220 related articles for article (PubMed ID: 28370518)
1. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor.
van Baaren GJ; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HCJ; Spaanderman MEA; Bloemenkamp KWM; Haak MC; Bax CJ; Cornette JMJ; Duvekot JJ; Nij Bijvanck BWA; van Eyck J; Franssen MTM; Sollie KM; Vandenbussche FPHA; Woiski M; Bolte AC; van der Post JAM; Bossuyt PMM; Opmeer BC; Mol BWJ
Ultrasound Obstet Gynecol; 2018 May; 51(5):596-603. PubMed ID: 28370518
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor.
van Baaren GJ; Vis JY; Grobman WA; Bossuyt PM; Opmeer BC; Mol BW
Am J Obstet Gynecol; 2013 Nov; 209(5):436.e1-8. PubMed ID: 23791688
[TBL] [Abstract][Full Text] [Related]
3. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women.
Bruijn M; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers H; Spaanderman M; Bloemenkamp K; Haak MC; Bolte AC; Vandenbussche F; Woiski MD; Bax CJ; Cornette J; Duvekot JJ; Nij Bijvanck B; van Eyck J; Franssen M; Sollie KM; van der Post J; Bossuyt P; Opmeer BC; Kok M; Mol B; van Baaren GJ
BJOG; 2016 Nov; 123(12):1965-1971. PubMed ID: 26667313
[TBL] [Abstract][Full Text] [Related]
4. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
[TBL] [Abstract][Full Text] [Related]
6. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME
Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
[TBL] [Abstract][Full Text] [Related]
7. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
[TBL] [Abstract][Full Text] [Related]
8. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
[No Abstract] [Full Text] [Related]
9. [Economical impact of preterm delivery management based on fetal fibronectin results].
García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the ability of cervical length and fetal fibronectin measurement to predict preterm delivery in asymptomatic women with risk factors.
Zhou MX; Zhou J; Bao Y; Chen YQ; Cai C
J Matern Fetal Neonatal Med; 2015 Jan; 28(2):153-7. PubMed ID: 24678648
[TBL] [Abstract][Full Text] [Related]
11. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
[TBL] [Abstract][Full Text] [Related]
12. Significance of cervical gland area in predicting preterm birth for patients with threatened preterm delivery: comparison with cervical length and fetal fibronectin.
Asakura H; Fukami T; Kurashina R; Tateyama N; Doi D; Takeshita T
Gynecol Obstet Invest; 2009; 68(1):1-8. PubMed ID: 19321961
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days.
Hermans FJR; Bruijn MMC; Vis JY; Wilms FF; Oudijk MA; Porath MM; Scheepers HCJ; Bloemenkamp KWM; Bax CJ; Cornette JMJ; Nij Bijvanck BWA; Franssen MTM; Vandenbussche FPHA; Kok M; Grobman WA; Van Der Post JAM; Bossuyt PMM; Opmeer BC; Mol BWJ; Schuit E; Van Baaren GJ
Acta Obstet Gynecol Scand; 2015 Jul; 94(7):715-721. PubMed ID: 25845495
[TBL] [Abstract][Full Text] [Related]
14. Predicting preterm birth: a cost-effectiveness analysis.
Mozurkewich EL; Naglie G; Krahn MD; Hayashi RH
Am J Obstet Gynecol; 2000 Jun; 182(6):1589-98. PubMed ID: 10871482
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.
Bruijn MM; Kamphuis EI; Hoesli IM; Martinez de Tejada B; Loccufier AR; Kühnert M; Helmer H; Franz M; Porath MM; Oudijk MA; Jacquemyn Y; Schulzke SM; Vetter G; Hoste G; Vis JY; Kok M; Mol BW; van Baaren GJ
Am J Obstet Gynecol; 2016 Dec; 215(6):793.e1-793.e8. PubMed ID: 27542720
[TBL] [Abstract][Full Text] [Related]
16. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour.
Audibert F; Fortin S; Delvin E; Djemli A; Brunet S; Dubé J; Fraser WD
J Obstet Gynaecol Can; 2010 Apr; 32(4):307-12. PubMed ID: 20500936
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women?
van Baaren GJ; Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvanck BW; van Eijck J; Franssen MT; Sollie KM; Vandenbussche FP; Woiski M; Bossuyt PM; Opmeer BC; Mol BW
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():79-85. PubMed ID: 26182836
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
[TBL] [Abstract][Full Text] [Related]
19. [Sequential use of cervical length measurement before fetal fibronectin detection to predict spontaneous preterm delivery in women with preterm labor].
Deplagne C; Maurice-Tison S; Coatleven F; Vandenbossche F; Horovitz J
J Gynecol Obstet Biol Reprod (Paris); 2010 Nov; 39(7):575-83. PubMed ID: 20884131
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of fetal fibronectin testing in clinical practice.
Cornelissen LGH; van Oostrum NHM; van der Woude DAA; Rolf C; Porath MM; Oei SG; van Laar JOEH
J Obstet Gynaecol Res; 2020 Mar; 46(3):405-412. PubMed ID: 31955485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
